highperformr logo

Kenneth A. Jacobson

Chief Financial Officer, Avnet
Phoenix, Arizona,United States
Find Kenneth A. Jacobson's Email
Find Kenneth A. Jacobson’s Phone

Kenneth A. Jacobson's Overview

Total Experience27 years
CompanyAvnet
CountryUnited States

Kenneth A. Jacobson is a highly distinguished medicinal chemist and Chief of the Molecular Recognition Section in the Laboratory of Bioorganic Chemistry at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH). His extensive research career is dedicated to the study of G protein-coupled receptors (GPCRs), particularly purinergic receptors (adenosine and P2Y receptors). Dr. Jacobson's laboratory focuses on designing, synthesizing, and evaluating novel ligands (agonists, antagonists, and allosteric modulators) for these receptors. The ultimate goal is to understand their structure-activity relationships and develop new therapeutic agents for a variety of conditions, including pain, inflammation, cancer, thrombosis, and metabolic disorders. He is recognized globally for his prolific contributions to GPCR pharmacology, with over 1000 scientific publications and numerous patents that have significantly advanced the field and provided critical tools for researchers worldwide.

Professional Summary

Kenneth A. Jacobson's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Avnet - Chief Financial Officer (2022 to Present)
First Solar - Director External Reporting and Technical Accounting (2011 to 2013)
PwC - Senior Manager- Audit (2001 to 2011)

Notable Achievements

Highly Cited Researcher

Consistently ranked as a highly cited researcher in Pharmacology and Toxicology, indicating significant influence and contribution to the scientific community through his extensive body of published work (over 1000 papers).

Pioneering Work on Purinergic Receptors

Led groundbreaking research in the design and synthesis of selective ligands for adenosine and P2Y receptors, many of which are now standard pharmacological tools and have led to candidates for clinical development.

ASPET Goodman and Gilman Award in Receptor Pharmacology

Recipient of the prestigious Goodman and Gilman Award in Receptor Pharmacology (2009) from the American Society for Pharmacology and Experimental Therapeutics (ASPET) for his outstanding contributions to the understanding of receptor pharmacology.

Numerous Patents on Novel Compounds

Co-inventor on a significant number of U.S. and international patents for novel chemical entities targeting GPCRs, highlighting the translational impact of his research in drug discovery.

NIH Director's Award

Recognized with multiple NIH Director's Awards for his scientific achievements and leadership within the National Institutes of Health.

Educational Background

BA, Accounting

University of Washington - Year 1998

United States Military Academy at West Point - Year 1996

Buying Intent Signals for Kenneth A. Jacobson

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Avnet
Total employees15800
HeadquartersPhoenix
Founded1921

Avnet is a global technology distributor and solutions provider with an extensive ecosystem that delivers design, product, marketing, and supply chain expertise for customers at every stage of the product lifecycle. They transform ideas into intelligent solutions, reducing the time, cost, and complexities of bringing products to market, serving electronic original equipment manufacturers (EOEMs) and electronic manufacturing services (EMS) providers.

Avnet Stock Information
Avnet, Inc. is listed on the NASDAQ under the ticker symbol AVT. The company went public on March 16, 1959

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.